Chinese Journal of Blood Purification ›› 2022, Vol. 21 ›› Issue (08): 545-459,568.doi: 10.3969/j.issn.1671-4091.2022.08.001

    Next Articles

Clinical Practice Recommendation for Arteriovenous Access Thrombosis Treatment

WANG Yu-zhu, ZHANG Li-hong, ZHAN Shen   

  1. Department of Nephrology, Haidian Hospital(Beijing Haidian Section of Peking University Third Hospital), Beijing 100080, China, 
  • Received:2022-03-14 Revised:2022-05-19 Online:2022-08-12 Published:2022-08-12
  • Contact: WANG Yu-zhu E-mail:zhanglihongzhu@163.com
  • Supported by:
    北京市海淀区卫生健康发展科研培育项目(HP2022-03-101001)

Abstract: Vascular access is the lifeline of maintenance hemodialysis patients. Arteriovenous fistula is the preferred vascular access, but it is prone to thrombosis which resulting in loss of fistula. Also, thrombosis is associated with hospitalization and all-cause mortality in maintenance hemodialysis patients. The establishment of vascular access and the treatment of complications in our country have made great progress in recent years, but there is a lack of systematic and standardized understanding of preoperative assessment, indications, method selection, technical points, and complication prevention for arteriovenous fistula thrombosis treatment. In view of this, the Department of Nephrology of Beijing Haidian Hospital drafted this recommendation with reference to relevant domestic and foreign literatures and a large amount of practical experience in our center, aiming to provide reference for nephrologists to standardize thrombosis treatment.

Key words: Vascular access, Arteriovenous fistula, Thrombosis, Treatment

CLC Number: